WO2025062181 - EX VIVO CANCER TISSUE CULTURE SYSTEM
National phase entry is expected:
Publication Number
WO/2025/062181
Publication Date
27.03.2025
International Application No.
PCT/IB2024/000519
International Filing Date
20.09.2024
Title **
[English]
EX VIVO CANCER TISSUE CULTURE SYSTEM
[French]
SYSTÈME DE CULTURE DE TISSU CANCÉREUX EX VIVO
Applicants **
CURESPONSE LTD
YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventors
SALPETER, Seth, Jonah
NEEV, Guy
BAR, Vered
STRAUSSMAN, Ravid
GAVERT, Nancy
Priority Data
63/539,686
21.09.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
ILPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3039 | |
| EPO | Filing, Examination, Granting | 25996 | |
| Japan | Filing, Examination, Granting | 3025 | |
| South Korea | Filing, Examination, Granting | 3858 | |
| USA | Filing, Examination, Granting | 9140 |
Total:
45,058
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are methods of culturing ex-vivo tissue, comprising culturing a tissue slice under a highly oxygenated atmosphere in the presence of an amount of an agent and agitating the culture. Also provided are methods of determining a therapeutically effective dose of an agent in the treatment of a disease or disorder using the ex-vivo tissue culture method.[French]
L'invention concerne des procédés de culture de tissu ex vivo, comprenant la culture d'une tranche de tissu sous une atmosphère hautement oxygénée en présence d'une quantité d'un agent, et l'agitation de la culture. L'invention concerne également des procédés de détermination d'une dose thérapeutiquement efficace d'un agent dans le traitement d'une maladie ou d'un trouble à l'aide du procédé de culture de tissu ex vivo.